Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock (or common stock equivalents) with Series E and Series F warrants Update: about US$9M · US$0.335 a share · Warrants at US$0.335 · A.G.P./Alliance Global Partners Dealers: A.G.P./Alliance Global Partners (lead) Use of proceeds: Research and development activities, working capital and other general corporate purposes | Sep 19, 2025 |
| Public offering of public equity offering Closed: US$10M raised · US$0.5 a share · Warrants at US$0.5 · A.G.P./Alliance Global Partners Dealers: A.G.P./Alliance Global Partners (lead) Use of proceeds: Research and development activities, working capital and other general corporate purposes | Aug 14, 2025 |
| Public offering of shares of common stock (or common share equivalents) and warrants Announced: about US$18M · US$1.5 a share · Warrants at US$1.5 · Citizens JMP +1 Dealers: Citizens JMP (lead), Citizens JMP Securities, LLC (lead) Use of proceeds: Fund research and development activities and for working capital and other general corporate purposes | Dec 16, 2024 |